Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis

Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison

(2010) Yu Wang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility

(2010) Y Wang et al.   BONE MARROW TRANSPLANTATION

Regression modeling of competing risk using R: an in depth guide for clinicians

(2010) L Scrucca et al.   BONE MARROW TRANSPLANTATION

Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation

(2009) Xiao-Jun Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect

(2009) X-J Huang et al.   BONE MARROW TRANSPLANTATION

Modified Donor Lymphocyte Infusion after HLA-Mismatched/Haploidentical T Cell-replete Hematopoietic Stem Cell Transplantation for Prophylaxis of Relapse of Leukemia in Patients with Advanced Leukemia

(2008) Xiao-Jun Huang et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Modified Donor Lymphocyte Infusion (DLI) for the Prophylaxis of Leukemia Relapse after Hematopoietic Stem Cell Transplantation in Patients with Advanced Leukemia—Feasibility and Safety Study

(2008) Xiao-Jun Huang et al.   JOURNAL OF CLINICAL IMMUNOLOGY